231 related articles for article (PubMed ID: 23388102)
1. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Marrie RA; Fisk JD; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Evans C; Wolfson C; Svenson LW; Tremlett H; Blanchard JF; Patten SB;
BMC Neurol; 2013 Feb; 13():16. PubMed ID: 23388102
[TBL] [Abstract][Full Text] [Related]
2. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.
Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
Neuroepidemiology; 2013; 40(2):85-92. PubMed ID: 23095571
[TBL] [Abstract][Full Text] [Related]
3. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
Mult Scler; 2012 Sep; 18(9):1310-9. PubMed ID: 22328682
[TBL] [Abstract][Full Text] [Related]
4. Differences in the burden of psychiatric comorbidity in MS vs the general population.
Marrie RA; Fisk JD; Tremlett H; Wolfson C; Warren S; Tennakoon A; Leung S; Patten SB;
Neurology; 2015 Dec; 85(22):1972-9. PubMed ID: 26519542
[TBL] [Abstract][Full Text] [Related]
5. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia.
Marrie RA; Fisk JD; Stadnyk KJ; Tremlett H; Wolfson C; Warren S; Bhan V; Yu BN;
Chronic Dis Inj Can; 2014 Jul; 34(2-3):145-53. PubMed ID: 24991777
[TBL] [Abstract][Full Text] [Related]
6. Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
BMC Res Notes; 2017 Nov; 10(1):619. PubMed ID: 29178935
[TBL] [Abstract][Full Text] [Related]
7. Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
Marrie RA; Patten SB; Greenfield J; Svenson LW; Jette N; Tremlett H; Wolfson C; Warren S; Profetto-McGrath J; Fisk JD; ; Blanchard J; Caetano P; Elliott L; Yu BN; Bhan V; Svenson L
Brain Behav; 2016 Sep; 6(9):e00493. PubMed ID: 27688933
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
J Psychosom Res; 2017 Oct; 101():17-23. PubMed ID: 28867419
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
McKay KA; Tremlett H; Fisk JD; Zhang T; Patten SB; Kastrukoff L; Campbell T; Marrie RA;
Neurology; 2018 Apr; 90(15):e1316-e1323. PubMed ID: 29523642
[TBL] [Abstract][Full Text] [Related]
10. Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease.
Marrie RA; Walker JR; Graff LA; Lix LM; Bolton JM; Nugent Z; Targownik LE; Bernstein CN;
J Psychosom Res; 2016 Oct; 89():107-13. PubMed ID: 27663119
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Marrie RA; Patten SB; Tremlett H; Wolfson C; Warren S; Svenson LW; Jette N; Fisk J;
Neurology; 2016 Apr; 86(14):1279-1286. PubMed ID: 26962066
[TBL] [Abstract][Full Text] [Related]
12. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data.
Marrie RA; Yu BN; Leung S; Elliott L; Warren S; Wolfson C; Tremlett H; Fisk J; Blanchard J
Neuroepidemiology; 2012; 39(2):135-42. PubMed ID: 22889755
[TBL] [Abstract][Full Text] [Related]
13. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2009 Mar; 15(3):385-92. PubMed ID: 19153176
[TBL] [Abstract][Full Text] [Related]
14. Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
Gen Hosp Psychiatry; 2018; 51():71-78. PubMed ID: 29353127
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.
Rotstein D; Maxwell C; Tu K; Gatley J; Pequeno P; Kopp A; Marrie RA
Mult Scler; 2021 Oct; 27(12):1902-1913. PubMed ID: 34328821
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
Kapica-Topczewska K; Tarasiuk J; Chorąży M; Czarnowska A; Brola W; Szczepański M; Kochanowicz J; Kułakowska A
Mult Scler Relat Disord; 2020 Jun; 41():102051. PubMed ID: 32197130
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort.
Johansson V; Lundholm C; Hillert J; Masterman T; Lichtenstein P; Landén M; Hultman CM
Mult Scler; 2014 Dec; 20(14):1881-91. PubMed ID: 25013151
[TBL] [Abstract][Full Text] [Related]
18. Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
Epidemiol Psychiatr Sci; 2019 Jun; 28(3):333-342. PubMed ID: 29098977
[TBL] [Abstract][Full Text] [Related]
19. Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.
Bernstein CN; Hitchon CA; Walld R; Bolton JM; Sareen J; Walker JR; Graff LA; Patten SB; Singer A; Lix LM; El-Gabalawy R; Katz A; Fisk JD; Marrie RA;
Inflamm Bowel Dis; 2019 Jan; 25(2):360-368. PubMed ID: 29986021
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Using a Nationally Representative Telephone Survey to Monitor Multiple Sclerosis Prevalence in the United States.
Buka SL; Wallin MT; Culpepper WJ; Lee YH; Marrie RA; Nelson LM; Kaye WE; Wagner L; Tremlett H; Campbell J; LaRocca N
Neuroepidemiology; 2020; 54(2):123-130. PubMed ID: 31991409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
